Latest Breaking News On - Alain sahel - Page 1 : comparemela.com

SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial with SPVN06 for retinitis pigmentosa

SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial with SPVN06 for retinitis pigmentosa
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesAmber fennellNathalie trepoDavide salviNamrata taakParis vision instituteSparingvision the companyFoundation fighting blindnessVision reaches final dose escalation stepData safety monitoring boardChief executive officerInvestigational new drugRetinitis pigmentosaIntellia therapeuticsAdvent france biotechnology

Tilak Healthcare Announces Positive Results From Its TIL002 Study Using the OdySight® App, Which Allows Patients With Retinal Diseases to Monitor Their Vision Themselves

Tilak Healthcare Announces Positive Results From Its TIL002 Study Using the OdySight® App, Which Allows Patients With Retinal Diseases to Monitor Their Vision Themselves
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

France generalOuest clinique jules vernesCentre ophtalmologique rabelaisProduct serviceWhich allows patients with retinal diseasesMonitor their visionInstitut ophtalmologiqueMedical directorTilak healthcareFrench articleProfessor josAlain sahel

Laurence Rodriguez, Appointed CEO of GenSight Biologics in December 2023, Joins the Company s Board of Directors

Laurence Rodriguez, Appointed CEO of GenSight Biologics in December 2023, Joins the Company s Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sanofi genzymeBernard gillyThomas gidoinGuillaume van renterghemGensight biologicsLaurence rodriguezNomination committeeBoard of directors the companyChief executive officerRare diseasesRare blood disordersAlain sahelSight biologicMitochondrial targeting sequenceLeber hereditary optic neuropathyGensight biologic

Laurence Rodriguez, Appointed CEO of GenSight Biologics in December 2023, Joins the Company s Board of Directors

Laurence Rodriguez, Appointed CEO of GenSight Biologics in December 2023, Joins the Company s Board of Directors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Guillaume van renterghemThomas gidoinBernard gillyLaurence rodriguezGensight biologicsSanofi genzymeBoard of directors the companyNomination committeeChief executive officerRare diseases blood disordersAlain sahelSight biologicMitochondrial targeting sequenceLeber hereditary optic neuropathyGensight biologic

Laurence Rodriguez, Appointed CEO of GenSight Biologics in December 2023, Joins the Company s Board of Directors

16.01.2024 - Regulatory News: The Board of Directors of GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (the Company ), a biopharma company focused on developing and commercializing innovative gene therapies for retinal .

Laurence rodriguezGensight biologicsSanofi genzymeBernard gillyChief executive officerRare diseasesRare blood disordersAlain sahelSight biologicMitochondrial targeting sequenceLeber hereditary optic neuropathyGensight biologicGensight biologics stock